EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vascular endothelial mineralocorticoid receptors and epithelial sodium channels in metabolic syndrome and related cardiovascular disease

Guanghong Jia iD, Michael A Hill, James R Sowers

Journal of Molecular Endocrinology · 2023

DOI: 10.1530/jme-23-0066 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Molecular Endocrinology, 2023. Verfasst von Guanghong Jia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine-Endocrinology and Metabolism, University of Missouri School of Medicine, Columbia, Missouri, USA. Hauptthemen laut MEDLINE: Metabolic Syndrome, Cardiovascular Diseases, Insulin Resistance. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic syndrome is a group of risk factors that increase the risk of developing metabolic and cardiovascular disease (CVD) and include obesity, dyslipidemia, insulin resistance, atherosclerosis, hypertension, coronary artery disease, and heart failure. Recent research indicates that excessive production of aldosterone and associated activation of mineralocorticoid receptors (MR) impair insulin metabolic signaling, promote insulin resistance, and increase the risk of developing metabolic syndrome and CVD. Moreover, activation of specific epithelial sodium channels (ENaC) in endothelial cells (EnNaC), which are downstream targets of endothelial-specific MR (ECMR) signaling, are also believed to play a crucial role in the development of metabolic syndrome and CVD. These adverse effects of ECMR/EnNaC activation are mediated by increased oxidative stress, inflammation, and lipid metabolic disorders. It is worth noting that ECMR/EnNaC activation and the pathophysiology underlying metabolic syndrome and CVD appears to exhibit sexual dimorphism. Targeting ECMR/EnNaC signaling may have a beneficial effect in preventing insulin resistance, diabetes, metabolic syndrome, and related CVD. This review aims to examine our current understanding of the relationship between MR activation and increased metabolic syndrome and CVD, with particular emphasis placed on the role for endothelial-specific ECMR/EnNaC signaling in these pathological processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeCardiovascular DiseasesInsulin ResistanceHumansReceptors, MineralocorticoidEpithelial Sodium ChannelsEndothelial Cells

Stichwörter der Autor:innen

endothelial cellsepithelial sodium channelsmetabolic syndromemineralocorticoid receptors

Substanzen

Receptors, MineralocorticoidEpithelial Sodium Channels

Autor:innen und Institutionen

  • Department of Medicine-Endocrinology and Metabolism, University of Missouri School of Medicine, Columbia, Missouri, USA.
  • Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri, USA.
  • Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, Missouri, USA.

ORCID-Profile: Guanghong Jia

Förderung

  • NIDDK NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Jia, G., Hill, M. A., & Sowers, J. R. (2023). Vascular endothelial mineralocorticoid receptors and epithelial sodium channels in metabolic syndrome and related cardiovascular disease. Journal of Molecular Endocrinology. https://doi.org/10.1530/jme-23-0066

Vancouver

Jia G, Hill MA, Sowers JR. Vascular endothelial mineralocorticoid receptors and epithelial sodium channels in metabolic syndrome and related cardiovascular disease. Journal of Molecular Endocrinology. 2023. doi:10.1530/jme-23-0066

BibTeX
@article{Jia2023,
  author = {Jia, Guanghong and Hill, Michael A and Sowers, James R},
  title = {Vascular endothelial mineralocorticoid receptors and epithelial sodium channels in metabolic syndrome and related cardiovascular disease},
  journal = {Journal of Molecular Endocrinology},
  year = {2023},
  doi = {10.1530/jme-23-0066}
}
Kostenlos starten →